Login

Mr. David Sin is the Co-Founder, Group President, and Deputy Chairman of the Board of Fullerton Health, and an alumnus of The Chinese High School. 00:10:00

Share On Facebook Share On Twitter

Chang Ching Wu CEO. Chief Executive Officer

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Chao Lab studies molecular machines that regulate membrane ultrastructure / Luke H Chao, Ph.D. Assistant Professor of Genetics, HMS
00:10:00
Exploring the Fusion of Music and Life Experiences
00:10:00
Base Resources: Leveraging Success in Mineral Sands Production and Expansion
00:10:00
"Marc Fiorentino, co-founder of Meilleurtaux Placement, hosts Jean-Michel Karam, founder of Memscap, for a presentation on this small-cap stock."|Jean-Michel Karam, founder of Memscap
00:00:00
Minimally Invasive Innovation for Consumers - Brennan J. Boettcher, D.O. Physiatrist, Mayo Clinic
00:10:00
FDA Grants Orphan Drug Designation to Cardiol Therapeutics' Lead Candidate for Recurrent Pericarditis| David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
Interview with Oris Minerals: Exploration and Development in Western Australia's Copper Belt
00:10:00
European Commercial Real Estate Sector Adapts to Economic Shifts and Embraces Logistics Amidst Higher Interest Rates | Simon Garing, CEO, Cromwell European Real Estate Investment Trust.
00:10:00
"Exploring Ethical Challenges and Global Investment Strategies: A Conversation with Alex Chitea, Managing Partner at Funston Capital"
00:10:00
Exciting Developments at Callinex Mines: CEO Max Porterfield Discusses Key Projects and Future Plans
00:10:00
Initialized GP Alda Leu Dennis on Negotiating Term Sheets|Alda Leu Dennis,General Partner,Initialized Capital
00:10:00
Common Investment Mistakes to Avoid for Financial Success

© 2017 - Neuhu+